The 9th International Summit on Cancer Research and Diagnosis will be organized during March 20-21, 2023 in Paris, France with the theme of Marching together toward a Cancer-free society. Cancer 2022 is a global platform for educational and scientific events for healthcare professionals who provide treatment and care in the areas of Oncology and academic researchers who conduct research work and clinical trials for human welfare. The Cancer Summit invites pathologists, oncologists, radiologists, academicians, clinical researchers, students, young researchers, medical devices companies and business delegates across the world to share ideas, exchange knowledge, and establish research collaborations & networking.
Session 1: Cancer biology
Cancer biology is the study of how the intracellular network of typical cells is disrupted during carcinogenesis in order to build successful predictive models that can help scientists and clinicians in the validation of new therapies and drugs. Cancer research is to identify causes and develop strategies for prevention, diagnosis, treatment, and cure.
Session 2: Epidemiology
The factors that cause the disease in order to establish disease-prevention strategies. The epidemiologic assessment provides a clinician with a comprehensive assessment of cancer risk, outlines the definition of screening modalities for high-risk populations and delineates the concept of cancer surveillance determines the efficacy of any preventive intervention.
Session 3: Early stage detection and screening
Unlike diagnostic efforts prompted by symptoms and medical signs, cancer screening involves efforts to detect cancer after it has formed, but before any noticeable symptoms appear. This may involve physical examination, blood or urine tests or medical imaging.
Session 4: Pathology and genetics
A pathology report is a medical document that gives information about a diagnosis, such as cancer. Pathologists are among the most important members of a patient’s cancer care team. They work to diagnose and determine the stage of cancer, setting the course for what comes next in the treatment journey. Cancer is a Genetic disease mainly caused due to alterations in different kinds of Genes. Cancers develop due to DNA Mutations and Epigenetics alterations and accumulate as a solid mass called a tumor.
Session 5: Pulmonology and radiology
Pulmonology deals with diseases involving the respiratory tract. It is also known as respiratory, respiratory medicine, or chest medicine in some countries and areas. Radiology is the medical discipline that uses medical imaging to diagnose and treat diseases within the bodies of animals and humans. Imaging tests can be used to look for cancer, find out how far it has spread, and help see if cancer treatment is working.
Session 6: Early-stage non-small cell cancer
Non-small cell lung cancer is a group of lung cancers that behave similarly, such as squamous cell carcinoma and adenocarcinoma. Symptoms are a cough that won't go away, shortness of breath, weight loss or coughing up blood. Treatments include surgery, chemotherapy and radiation.
Session 7: Palliative and supportive care
The aim of palliative treatment is to relieve symptoms and improve your quality of life. It can be used at any stage of an illness if there are troubling symptoms, such as pain or sickness. In advanced cancer, palliative treatment might help someone to live longer and more comfortably, even if they cannot be cured.
Session 8: Nursing and health professionals
Oncology nursing care can be defined as meeting the various needs of oncology patients during the time of their disease including appropriate screenings and other preventive practices, symptom management, care to retain as much normal functioning as possible, and supportive measures upon the end of life.
Session 9: Patients advocacy
Patient advocacy is an area of specialization in health care concerned with advocacy for patients, survivors, and caregivers. The patient advocate may be an individual or an organization, often, though not always, concerned with one specific group of disorders.
Session 10: Management of cancer in the COVID-19 era
The rapidly expanding COVID-19 pandemic impacted all areas of daily life, including medical care. In particular, delivering care for patients with cancer or suspected cancer during this crisis has been challenging given the competing risks of death from untreated cancer versus serious complications from SARS-CoV-2, and the likely higher lethality of COVID-19 in immunocompromised hosts.
Session 11: Cancer stem cell therapy
Cells that are present in tumors and have the capabilities of self-renewing and the ability to give rise to many cells are known as cancer stem cells. The cancer stem cell model is also known as the hierarchical model process. Cellular therapies are a part of complementary treatment regimens.
Session 12: Global health research and health economics
Oncology continues to be a major focus for all healthcare stakeholders, attracting intense investments in drug development for new therapies and diagnostics that keep fueling innovation while increasing concerns for the ever-rising cost of cancer care. The call for value-based strategies in oncology has become mainstream, with providers, payers, drug manufacturers, and ultimately patients searching for ways to improve access to new therapies and best practices, implementing clinical pathways, new reimbursement metrics, and patient support services.
Cancer is the second leading cause of death worldwide. It's crucial to remember that cancer is not one disease, its more than 200 cancer diseases involved. All different, unique diseases, require different approaches for treatment. According to the US-based Cancer Research Institute, different types of cancer were responsible for around 9.6 million deaths in the world in the year 2018. Additionally, approximately 18 million cases of cancer were reported in the same year. Cancer has always been one of the most intimidating diseases in the world with a high chance of fatality. Detrimental lifestyle changes are responsible for consistently rising statistics of cancer patients in the world, which in turn has generated a high demand for the oncology market. Oncology has been fundamental in the prevention of cancer throughout the world because of advanced diagnosis, and timely prevention to lessen exposure to tobacco, smoking, and consumption of alcohol. The oncology market will witness remarkable growth in the upcoming years with the increase in disposable income, the booming medical technology sector, and elevated demand for cancer treatment. During the forecast period of 2019-2025, the market is expected to grow with a burgeoning compound annual growth rate (CAGR) of 12.6%. In 2018, the size of the global market was estimated at $120 billion. Only worldwide research will enhance our understanding of cancer and help us find and develop better, more effective treatments. And only a global search for answers will help us get to grips with this disease. The conference will provide an exceptional opportunity for the delegates from Universities and Institutes to interact with the world-class Scientists and Industry Professionals working in the field of cancer (or) oncology.
Cancer 2023 helps to inform and attract new customers quickly and efficiently. The size and diversity of our advertising options, including banners, sponsored emails, article alerts or newsletters, provide clients with the very best customized marketing opportunities in science and medicine. We are one of the renowned event organizing platforms with the most eminent speakers and business audiences from all over the globe indexed. The advertising platform we provide you is the best chance of showcasing your products/services, and brand your company. If you are looking for global exposure for your products and services, this is the right place for you. With over 5 million readers worldwide and nearly 3 million hits a month on our website, we have an engaged audience of students, research scholars, scientists, doctors, professors, pharmacists and professionals from companies across the territories. If you sell research materials, products, medicinal instruments, or services like rehabilitation centers, here is your opportunity to advertise on the website that can connect you to leading experts and science specialists across the Globe. Advertisement banners must be provided in high-resolution jpg or jpeg format by the advertising company and must not have copyright infringement. We can also support your events and conferences by providing you with high-quality reprints of published articles that can add value to your event.
Meetings International is announcing the Young Scientist Awards through the 9th International Summit on Cancer Research and Diagnosis which is scheduled in Paris France during March 20-21, 2023. This Cancer 2023 focuses on Marching together toward a cancer-free society. The cancer research meeting and upcoming conferences will recognize participants who have significantly added value to the scientific community of Medical science and provide them with outstanding Young Scientist Awards. The Young Scientist Award will provide a strong professional development opportunity for young researchers by meeting experts to exchange and share their experiences at our international conferences. The conference operating committee is providing a platform for all the budding young researchers, young investigators, post-graduate/Master's students, Ph.D. students and trainees to showcase their research and innovation.
Eligibility: Young Scientists, faculty members, post-doctoral fellows, Ph.D. scholars and Final Year MSc and M.Phil. Candidates Persons from Scientific Industry can also participate.
The Young Scientist Feature is a platform to promote young researchers in their respective areas by giving them a chance to present their achievements and future perspectives.
Acknowledgment as YRF Awardee.
Promotion on the conference website,
Young Scientist Awards and certificates.
Link on the conference website.
Recognition on Meetings Int. Award Page.
Chances to coordinate with partners around the world.
Research work can be published in the relevant journal without any publication fee.
All presented abstracts will automatically be considered for the Award. All the presentations will be evaluated in the conference venue.
All the awards will be selected by the judges of the award category.
The winners of the Young Scientist Award will receive an award certificate.
The awards will be assessed as far as plan and format, intelligence, argumentation and approach, familiarity with past work, engaging quality, message and primary concerns, parity of content visuals, and by and large impression.
All submissions must be in English.
The topic must fit into the scientific sessions of the conference.
Each individual participant is allowed to submit a maximum of 2 papers.
The abstract must be submitted online as per the given abstract template.
Abstracts must be written in Times New Roman and font size will be 12.
An abstract must contain a title, name, affiliation, country, speaker's biography, recent photograph, image and reference.
Conditions of Acceptance: To receive the award, the awardee must submit the presentation for which the award is given, for publication on the website, along with author permission. Failure to submit the PPT and permission within the designated timeframe will result in forfeiture of the award.
Award Announcements: Official announcement of the recipients will occur after the completion of Cancer 2022.
Learning In a New Space
New Tips & Tactics